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Background
Based on the partial efficacy of the HIV/AIDS Thai trial
(RV144) with a canarypox vector prime and protein
boost, attenuated poxvirus recombinants expressing
HIV-1 antigens are increasingly sought as vaccine candi-
dates against HIV/AIDS.
Methods
Here we describe using systems analysis the biological
and immunological characteristics of the attenuated vac-
cinia virus Ankara strain expressing the HIV-1 antigens
Env/Gag-Pol-Nef of HIV-1 of clade C (referred as
MVA-C).
Results
MVA-C infection of human monocyte derived dendritic
cells (moDCs) induced the expression of HIV-1 antigens
at high levels from 2 to 8 hpi and triggered moDCs
maturation as revealed by enhanced expression of HLA-
DR, CD86, CD40, HLA-A2 and CD80 molecules. Infec-
tion ex vivo of purified mDC and pDC with MVA-C
induced the expression of immunoregulatory pathways
associated with antiviral responses, antigen presentation,
T cell and B cell responses. Similarly, human whole
blood or primary macrophages infected with MVA-C
express high levels of proinflammatory cytokines and
chemokines involved with T cell activation. The vector
MVA-C has the ability to cross-present antigens to
HIV-specific CD8 T cells in vitro and to increase CD8
T cell proliferation in a dose-dependent manner. The
immunogenic profiling in mice after DNA-C prime/
MVA-C boost combination revealed activation of HIV-
1-specific CD4 and CD8 T cell memory responses, that
are polyfunctional and with effector memory phenotype.
Env-specific IgG binding antibodies were also produced
in animals receiving DNA-C prime/MVA-C boost.
Conclusion
Our systems analysis of profiling immune response to
MVA-C infection highlights the potential benefit of
MVA-C as vaccine candidate against HIV/AIDS for
clade C, the prevalent subtype virus in the most affected
areas of the world.
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